Predictive value of clinical parameters in responses to epidermal growth factor-tyrosine kinase inhibitors as first-line therapy for stage Ⅳ non-small cell lung cancer

by ZHENG Linpeng, XU Zihan, ZHU Guangkuo, LI Feng, YANG Qiao
Published 2019-02-01